Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Keppel Corporation Ltd | KEP1 | 17. mar 2025 | 4.59 | +0.72 |
KEPPEL REIT UTS | H27 | 17. mar 2025 | 0.58 | +0.07 |
Kering | PPXB | 17. mar 2025 | 21.60 | 0.00 |
Kering SA | PPX | 17. mar 2025 | 218.70 | -2.08 |
Kerlink | 344 | 17. mar 2025 | 0.51 | +1.59 |
Kernel Holding SA | 0KE | 17. mar 2025 | 5.21 | +0.97 |
Kerry Group Plc | KRZA | 17. mar 2025 | 94.50 | 0.00 |
Kerry Group Plc | KRZ | 17. mar 2025 | 96.00 | +0.37 |
KERRY LOG NET | KYL | 17. mar 2025 | 0.84 | +3.07 |
KERRY PPT | KR3 | 17. mar 2025 | 2.14 | -0.93 |
KESKO A | KEK1 | 17. mar 2025 | 18.46 | +1.10 |
Kesko B | KEK | 17. mar 2025 | 18.51 | -1.88 |
Kesselrun Resources Ltd | CMG | 17. mar 2025 | 0.02 | 0.00 |
Keurig Dr Pepper Inc. | DP5 | 17. mar 2025 | 31.08 | +1.04 |
Kewaunee Scientific | KEW | 17. mar 2025 | 43.00 | -3.59 |
Kewpie Corporation | QPJ | 17. mar 2025 | 17.70 | 0.00 |
Key Tronic Corporation | KT1 | 17. mar 2025 | 2.42 | 0.00 |
KeyCorp | KEY | 17. mar 2025 | 14.21 | +1.79 |
Keyence Corporation | KEE | 17. mar 2025 | 375.20 | -0.77 |
Keyera Corp | K2Y | 17. mar 2025 | 26.28 | -1.65 |
Keymed Biosciences Inc. | 64Z | 17. mar 2025 | 4.06 | +0.50 |
Keyrus Progiware | 5UP | 17. mar 2025 | 7.12 | -0.56 |
Keysight Technologies Inc | 1KT | 17. mar 2025 | 140.36 | +2.29 |
Keyware Technologies NV | KY3A | 17. mar 2025 | 0.78 | 0.00 |
Kezar Life Sciences | 2KZ0 | 17. mar 2025 | 5.35 | 0.00 |
Kezar Life Sciences, Inc. | 2KZ | 17. mar 2025 | 6.95 | 0.00 |
Kforce, Inc. | ROF | 17. mar 2025 | 46.40 | +2.65 |
KGHM Polska Miedz S.A. | KGHA | 17. mar 2025 | 32.80 | +0.03 |
KGL Resources Limited | KN6 | 17. mar 2025 | 0.04 | -16.49 |
KHD Humboldt Wedag International AG | KWG | 17. mar 2025 | 1.87 | +3.89 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.